ArticleCell and tissue banking2023
Relative influence on cell behaviors of osteoblasts seeded onto demineralized bone matrix with diverse particle size.
Article in Cell and tissue banking, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Enhancement of in vitro and in vivo bone repair performance of decalcified bone/gelma by desferrioxamine.Scientific reports · 2025Article
- Optimization of 3D Extrusion-Printed Particle-Containing Hydrogels for Osteogenic Differentiation.ACS omega · 2025Article
- 3D-Printed Demineralized Bone Matrix-Based Conductive Scaffolds Combined with Electrical Stimulation for Bone Tissue Engineering Applications.ACS applied bio materials · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Demineralized bone matrix (DBM) is a natural and collagen-based allogeneic bone graft material with good bioactivity and biocompatibility. However, there are conflicting reports on the efficiency of this product owning to the relevant factors, especially, the particle size of DBM. In the current study, osteoblasts were seeded onto DBM with diverse particle sizes of 0.6-1.0 mm, 2.2-2.6 mm, 3.8-4.2 mm and 5.4-5.8 mm, and then the cell adhesion, proliferation, differentiation and apoptosis were analyzed to evaluate the effects of particle sizes on bioactivity and biocompatibility of DBM. It could be identified that particle size had a significant influence on the surface roughness and the collagen structure of DBM. In-vitro cytological assays had confirmed that DBM with all particle sizes had good cytocompatibility, which was beneficial for cell survival. What's more, DBM with a smaller particle size had a better biological activity and could promote cell proliferation and differentiation. We hope that researchers could choose to apply DBM with particle size of 0.6-1.0 mm for further intensive study, from which researchers will acquire more comparable and reliable conclusions for different study purposes.
Indexed as
Identifiers
36222967What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.